Search | IOVS | ARVO Journals

View

Showing 1 – 13 of 13

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

Real-life outcomes of dexamethasone intravitreal implant (Ozurdex) in diabetic macular oedema for treatment-naive eyes compared to anti-VEGF non-responders at three months post-treatment

Ali Essam Ghareeb; Tiffany Lau; Mila Kishikova; Ajay Kotagiri; Ibrahim Masri; Jonathan Smith; Deepali Varma; David Steel; Maged Habib

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1047. doi:

ARVO Annual Meeting Abstract June 2021

Functional and Structural Outcomes of Patients with Diabetic macular oedema treated with multiple Ozurdex implants at 24 months – Real Life Data

Tiffany Lau; Ali Essam Ghareeb; Mila Kishikova; Ajay Kotagiri; Ibrahim Masri; Jonathan Smith; Deepali Varma; David Steel; Maged Habib

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1046. doi:

ARVO Annual Meeting Abstract July 2019

Real-life long-term outcomes for patients receiving intra-vitreal Aflibercept for neovascular age related macular degeneration (nAMD): five(5)-year follow-up

Ankur Mehta; Matthew Hartley; Majed Habib; Ajay Kotagiri; David Steel; Smith Jonathan; Deepali Varma

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):83. doi:

ARVO Annual Meeting Abstract July 2018

Treatment of neovascular Age related macular degeneration (AMD) using a Modified ‘Treat and Extend regimen’

Rehab Ismail; Deepali Varma

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):801. doi:

ARVO Annual Meeting Abstract June 2017

Long-term real world outcomes in younger (under 60yrs) patients receiving anti-VEGF therapy for choridal neovascular membrane (CNVM).

Lyudmila Kishikova; Yewande Babalola; Maged S Habib; Deepali Varma; David Steel; Jonathan Smith; Maria T Sandinha; Ajay Kumar Kotagiri

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):418. doi:

ARVO Annual Meeting Abstract June 2017

Real life long term outcomes of patients receiving intra-vitreal Aflibercept for Neo-vascular age related macular degeneration (nAMD): three years follow up.

Yewande Babalola; Lyudmila Kishikova; Maged S Habib; Deepali Varma; Jonathan Smith; Maria T Sandinha; David Steel; Ajay Kotagiri

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):423. doi:

ARVO Annual Meeting Abstract June 2017

Real life experience of combined fixed-dosing and Treat and Extend protocols for the treatment of Diabetic Macular Oedema (DMO) with Anti-Vascular Endothelial Growth Factors (VEGF) agents

Karim El-Assal; Alex Stubbing-Moore; Caspar Geenen; Deepali Varma; Ajay Kumar Kotagiri; Jonathan Smith; David H W Steel; Maged S Habib

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1899. doi:

ARVO Annual Meeting Abstract June 2017

Real life experience of combined fixed-dosing and Treat and Extend protocols for intravitreal Aflibercept injections for Macular Oedema secondary to Central Retinal Vein Occlusion (CRVO)

Caspar Geenen; Karim El-Assal; David Steel; Deepali Varma; Ajay Kotagiri; Jonathan Smith; Maria T Sandinha; Maged S Habib

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3649. doi:

ARVO Annual Meeting Abstract September 2016

Are the initial treatment results of Ranibizumab for Diabetic Macular Oedema maintained at 1 year with Pro re nata protocol? A real life experience.

Ajay Kumar Kumar Kotagiri; Maged Habib; Alex Stubbing-Moore; Dalvir Bajwa; Deepali Varma; Maria Teresa Sandinha; Jonathan Smith; David Steel

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2099. doi:

ARVO Annual Meeting Abstract June 2015

Real life clinical audit on Neo-vascular age related macular degeneration (nAMD) - comparing fixed dose Aflibercept versus PRN Ranibizumab (RBZ) over 12 months.

Romeela Layale Rana-Rahman; Ajay Kotagiri; Maged Habib; Jonothan Smith; Sandhina Teresa; David Steel; Deepali Varma; none

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4618. doi:

ARVO Annual Meeting Abstract April 2014

Short-term outcomes of aflibercept therapy for exudative age-related macular degeneration with persistent fluid on ranibizumab.

Alexandros Deligiannidis; Ajay K Kotagiri; Deepali Varma; Andrew Browning; Rajen Gupta; James S Talks

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4980. doi:

ARVO Annual Meeting Abstract April 2014

Aflibercept-Real life clinical data in the management of Wet age related macular degeneration (Wet AMD)

Ajay K Kotagiri; James S Talks; Deepali Varma; Rajen Gupta; Andrew Browning; Rajeev Kak

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):578. doi:

ARVO Annual Meeting Abstract March 2012

Improved Response To Ranibizumab In Ex And Current Smokers With Age-related Macular Degeneration (AMD), But No Evidence That CFH, ARMS2/HTRA1 Or VEGF Genotypes Predict Treatment Outcome

Chris F. Inglehearn; Manir Ali; Richard Gale; Frances Cassidy; Deepali Varma; Louise M. Downey; Paul D. Baxter; Martin McKibbin

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3325. doi:

Advertisement